Admiral Scott Moore joins Board of Directors of Wild Things, LLC.
NEW YORK, Oct. 15, 2019, /PRNewswire/ -- Wild Things, LLC ("Wild Things" or the "Company"), an ASGARD Partners & Co. ("ASGARD") portfolio company, today announced that Admiral Scott Moore has joined its Board of Directors. Admiral Moore retired in 2014 as a [...]
ASGARD Announces Amy Coyne as CEO of Revision Military, Ltd
NEW YORK, October 10, 2019, – Revision Military Ltd (“Revision Military” or the “Company”), an ASGARD Partners & Co. (“ASGARD”) portfolio company, announced that industry veteran Amy Coyne has joined as Chief Executive Officer (“CEO”). Ms. Coyne has over 23 [...]
Asgard Partners & Co. Acquires Revision Eyewear Business
NEW YORK (October 2, 2019) – ASGARD Partners & Co. (“ASGARD”), a private equity firm based in New York, and Merit Capital Partners (“Merit”), a private equity firm based in Chicago, have partnered to acquire the eyewear business of Revision Military Limited (“Revision” or the “Company”), the [...]
ASGARD Advisory Delivers Success for Clients in 2018
ASGARD Advisory assisted clients with $100 Million+ of Capital Raising in first full year of operation. 2018 Notable Transactions Our Value Proposition Advisory Services Transaction Criteria Preferred Sectors Senior Debt Junior Debt Venture Debt Growth Debt M&A Advisory Revenue $15-$150 MM Capital [...]
ASGARD Advises Global Knowledge Training on $10 Million Receivables Facility
NEW YORK, Dec. 14, 2018, /PRNewswire/ -- ASGARD Partners & Co. ("ASGARD") is pleased to announce that is has advised Global Knowledge Training LLC ("Global Knowledge"), the worldwide leader in IT and business skills training, on its $10 million receivables facility. Bob Kalainikas, CFO of [...]
ASGARD Advises Avadim Health, Inc. on $60 Million Financing
NEW YORK, Oct. 10, 2018, /PRNewswire/ -- ASGARD Partners & Co. ("ASGARD"), a leading middle-market investment and advisory firm, is pleased to announce today that it has acted as exclusive advisor to Avadim Health, Inc. ("Avadim Health"), the Bionome Therapies™ life [...]
Joseph J. Adipietro Joins ASGARD’s New York Office as Managing Director and Co-Head of Advisory
NEW YORK, Sept. 17, 2018, /PRNewswire/ -- ASGARD Partners & Co. ("ASGARD"), a leading middle-market investment and advisory firm, announced today that Joseph J. Adipietro has joined the New York office as Managing Director and Co-Head of the firm's Advisory Group. Joe will lead [...]
ASGARD Partners & Co. Engaged as Capital Markets Advisor for Bcause LLC’s $25 Million Series B Capital Raise
NEW YORK, NY, May 21, 2018, -- BCause LLC, creator of what is believed to be the world's first full-stack cryptocurrency ecosystem, today announced that the firm has engaged ASGARD Partners & Co.* as its exclusive Capital Markets Advisor for a Series B [...]
ASGARD Partners & Co. Advises Avadim Technologies on $17 Million Financing
NEW YORK, NY, May 02, 2018, — ASGARD Partners & Co. (“ASGARD”) is pleased to announce that is has advised Avadim Technologies Inc. (“Avadim”), the Bionome TherapiesTM life sciences company, on its $17 million equity and debt financing round. Both existing [...]
ASGARD Partners & Co. Strengthens Capital Markets Group with New Hire
NEW YORK, April 18, 2018, /PRNewswire/ -- ASGARD Partners & Co. ("ASGARD"), a leading investment and advisory firm, announced that Andi Çomo has joined the firm's Capital Markets group as a Managing Director. Andi will focus on providing customized solutions to [...]
ASGARD Partners & Co. Hires Blackstone Alum to Bolster Private Equity Group
NEW YORK, March 26, 2018, /PRNewswire/ -- ASGARD Partners & Co. ("ASGARD"), an investment firm based in New York, is pleased to announce the hire of Tina Pham as its Director of Business Development for its Private Equity Group. With the addition of [...]